Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 19, 2013
Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation Development.
read more
Friday, September 20, 2013
Coldstream Laboratories, Inc., a provider of parenteral manufacturing and sterile drug product development services, has announced that Pamela Savoy has joined the company as Director of Business Development. In this position, Ms. Savoy will be ...
read more
Cognate BioServices, a contract development and manufacturing organization in the global cellular therapies industry, has secured a financial sponsor to support its short-term and long-term growth as it closed on a round of growth capital from EW ...
read more
Lannett has informed the approximately 80 employees at its Cody Labs subsidiary it has decided to cease operations and close its facility in Wyoming.
read more
Codexis has announced the signing of a collaboration and license agreement with Takeda for the research and development of novel gene therapies for certain disease indications.
read more
Wednesday, October 07, 2020
Cobra Biologics and Scancell Holdings have entered into a collaboration for Cobra to manufacture Scancell’s COVID-19 vaccine.
read more
Cobra Biologics has signed an agreement with AstraZeneca to manufacture the adenovirus vector-based COVID-19 vaccine candidate AZD1222.
read more
Monday, February 13, 2012
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of three non-executive directors to Cobra Biologics’ board, and two business development managers tasked with driving ...
read more
Wednesday, February 21, 2018
Cobra Biologics and Symbiosis Pharmaceutical Services announced that they have been awarded a 16-month collaborative grant of £1.9m ($2.5m) from Innovate UK.
read more
Cobra has successfully produced and supplied two further DNA plasmids for the production of CombiGene’s gene therapy drug candidate CG01.
read more
Wednesday, August 19, 2020
Cobra Biologics CombiGene announced Cobra has successfully produced master cell banks for the three plasmids used as starting material for CombiGene’s gene therapy CG01.
read more
Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Vaccibody AS, a biotechnology company developing the next generation of vaccines against cancer and chronic infections, today announce an...
read more
Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Recopharma, a biotechnology company developing ophthalmic products, today announce an agreement to supply a human Fc fusion protein using...
read more
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals and KAHR Medical Limited, that develops novel drugs based on the Signal Converter Proteins (SCP) technology for the treatment of cancer and ...
read more
Cobra Biologics, a leading contract manufacturer of clinical and commercial scale biologics and pharmaceuticals, and targeted cancer therapy company BioCancell have announced an agreement to manufacture BioCancell’s BC-821 cancer drug for clinical ...
read more